| Year |
Citation |
Score |
| 2022 |
Qin T, Chen K, Li J, Qian W, Xiao Y, Wu E, Ma J, Chen Z, Wang Z, Ma Q, Wu Z. Heat shock factor 1 inhibition sensitizes pancreatic cancer to gemcitabine via the suppression of cancer stem cell-like properties. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 148: 112713. PMID 35158144 DOI: 10.1016/j.biopha.2022.112713 |
0.33 |
|
| 2020 |
Li Y, Burgman B, McGrail DJ, Sun M, Qi D, Shukla SA, Wu E, Capasso A, Lin SY, Wu CJ, Eckhardt SG, Mills GB, Li B, Sahni N, Yi SS. Integrated Genomic Characterization of the Human Immunome in Cancer. Cancer Research. PMID 32855206 DOI: 10.1158/0008-5472.Can-20-0384 |
0.315 |
|
| 2020 |
Qin T, Cheng L, Xiao Y, Qian W, Li J, Wu Z, Wang Z, Xu Q, Duan W, Wong L, Wu E, Ma Q, Ma J. NAF-1 Inhibition by Resveratrol Suppresses Cancer Stem Cell-Like Properties and the Invasion of Pancreatic Cancer. Frontiers in Oncology. 10: 1038. PMID 32766132 DOI: 10.3389/fonc.2020.01038 |
0.331 |
|
| 2020 |
Shao S, Qin T, Qian W, Li X, Li W, Han L, Zhang D, Wang Z, Ma Q, Wu Z, Wu E, Lei J. Cav-1 Ablation in Pancreatic Stellate Cells Promotes Pancreatic Cancer Growth through Nrf2-Induced shh Signaling. Oxidative Medicine and Cellular Longevity. 2020: 1868764. PMID 32377291 DOI: 10.1155/2020/1868764 |
0.449 |
|
| 2019 |
Jiang Z, Liang G, Xiao Y, Qin T, Chen X, Wu E, Ma Q, Wang Z. Targeting the SLIT/ROBO pathway in tumor progression: molecular mechanisms and therapeutic perspectives. Therapeutic Advances in Medical Oncology. 11: 1758835919855238. PMID 31217826 DOI: 10.1177/1758835919855238 |
0.346 |
|
| 2019 |
Qi D, Wang F, Fonkem E, Huang JH, Wu E. Abstract 1122: CD44 as potential therapeutic target for medulloblastoma metastasis Cancer Research. 79: 1122-1122. DOI: 10.1158/1538-7445.Am2019-1122 |
0.316 |
|
| 2018 |
Sun L, Cao J, Chen K, Cheng L, Zhou C, Yan B, Qian W, Li J, Duan W, Ma J, Qi D, Wu E, Wang Z, Liu Q, Ma Q, et al. Betulinic acid inhibits stemness and EMT of pancreatic cancer cells via activation of AMPK signaling. International Journal of Oncology. PMID 30365057 DOI: 10.3892/ijo.2018.4604 |
0.349 |
|
| 2018 |
Cao J, Ma J, Sun L, Li J, Qin T, Zhou C, Cheng L, Chen K, Qian W, Duan W, Wang F, Wu E, Wang Z, Ma Q, Han L. Targeting glypican-4 overcomes 5-FU resistance and attenuates stem cell-like properties via suppression of Wnt/β-catenin pathway in pancreatic cancer cells. Journal of Cellular Biochemistry. PMID 30010221 DOI: 10.1002/Jcb.27266 |
0.425 |
|
| 2017 |
Chen X, Sheng L, Ma J, Jiang Z, Xu Q, Lei J, Duan W, Nan L, Li X, Wang Z, Wu Z, Xu J, Wang F, Huang JH, Wu E, et al. NNK promotes chronic pancreatitis to pancreatic intraepithelial neoplasia and accelerates pancreatic cancer migration Oncotarget. DOI: 10.18632/Oncotarget.23669 |
0.332 |
|
| 2016 |
Duan W, Chen K, Jiang Z, Chen X, Sun L, Li J, Lei J, Xu Q, Ma J, Li X, Han L, Wang Z, Wu Z, Wang F, Wu E, et al. Desmoplasia Suppression by Metformin-mediated AMPK Activation Inhibits Pancreatic Cancer Progression. Cancer Letters. PMID 27773749 DOI: 10.1016/J.Canlet.2016.10.019 |
0.392 |
|
| 2016 |
Han L, Ma J, Duan W, Zhang L, Yu S, Xu Q, Lei J, Li X, Wang Z, Wu Z, Huang JH, Wu E, Ma Q, Ma Z. Pancreatic stellate cells contribute pancreatic cancer pain via activation of sHH signaling pathway. Oncotarget. PMID 26934446 DOI: 10.18632/Oncotarget.7776 |
0.303 |
|
| 2016 |
Wang F, Shen X, Pruszynski J, Huang J, Kirmani B, Wu E, Fonkem E. Abstract 465: CD44 as a potential therapeutic target and prognosis marker for glioblastoma Cancer Research. 76: 465-465. DOI: 10.1158/1538-7445.Am2016-465 |
0.311 |
|
| 2015 |
Wang X, Duan W, Li X, Liu J, Li D, Ye L, Qian L, Yang A, Xu Q, Liu H, Fu Q, Wu E, Ma Q, Shen X. PTTG regulates the metabolic switch of ovarian cancer cells via the c-myc pathway. Oncotarget. PMID 26516926 DOI: 10.18632/Oncotarget.5726 |
0.415 |
|
| 2015 |
Zhang D, Lei J, Ma J, Chen X, Sheng L, Jiang Z, Nan L, Xu Q, Duan W, Wang Z, Li X, Wu Z, Wu E, Ma Q, Huo X. β2-Adrenogenic signaling regulates NNK-induced pancreatic cancer progression via upregulation of HIF-1α. Oncotarget. PMID 26497365 DOI: 10.18632/Oncotarget.5677 |
0.364 |
|
| 2015 |
Li W, Ma Z, Ma J, Li X, Xu Q, Duan W, Chen X, Lv Y, Zhou S, Wu E, Ma Q, Huo X. Hydrogen peroxide mediates hyperglycemia-induced invasive activity via ERK and p38 MAPK in human pancreatic cancer. Oncotarget. PMID 26439801 DOI: 10.18632/Oncotarget.5045 |
0.42 |
|
| 2015 |
Ding X, Ma M, Teng J, Wu E, Wang X. Numb Protects Human Renal Tubular Epithelial Cells from Bovine Serum Albumin-Induced Apoptosis Through Antagonizing CHOP/PERK Pathway. Journal of Cellular Biochemistry. PMID 26096024 DOI: 10.1002/Jcb.25261 |
0.329 |
|
| 2015 |
Wang X, Ma M, Teng J, Zhang J, Zhou S, Zhang Y, Wu E, Ding X. Chronic exposure to cerebrospinal fluid of multiple system atrophy in neuroblastoma and glioblastoma cells induces cytotoxicity via ER stress and autophagy activation. Oncotarget. 6: 13278-94. PMID 25965819 DOI: 10.18632/Oncotarget.3748 |
0.31 |
|
| 2015 |
Li J, Ma J, Han L, Xu Q, Lei J, Duan W, Li W, Wang F, Wu E, Ma Q, Huo X. Hyperglycemic tumor microenvironment induces perineural invasion in pancreatic cancer. Cancer Biology & Therapy. 16: 912-21. PMID 25946624 DOI: 10.1080/15384047.2015.1040952 |
0.43 |
|
| 2015 |
Ding X, Ma M, Teng J, Shao F, Teng RK, Zhou S, Zhang Y, Wu E, Wang X. Numb induces e-cadherin adhesion dissolution, cytoskeleton reorganization, and migration in tubular epithelial cells contributing to renal fibrosis. Current Molecular Medicine. 15: 368-79. PMID 25941814 DOI: 10.2174/1566524015666150505162015 |
0.327 |
|
| 2015 |
Ma J, Duan W, Han S, Lei J, Xu Q, Chen X, Jiang Z, Nan L, Li J, Chen K, Han L, Wang Z, Li X, Wu E, Huo X. Ginkgolic acid suppresses the development of pancreatic cancer by inhibiting pathways driving lipogenesis. Oncotarget. PMID 25895130 DOI: 10.18632/Oncotarget.3663 |
0.404 |
|
| 2015 |
Xu Q, Wang Z, Chen X, Duan W, Lei J, Zong L, Li X, Sheng L, Ma J, Han L, Li W, Zhang L, Guo K, Ma Z, Wu Z, ... Wu E, et al. Stromal-derived factor-1α/CXCL12-CXCR4 chemotactic pathway promotes perineural invasion in pancreatic cancer. Oncotarget. 6: 4717-32. PMID 25605248 DOI: 10.18632/Oncotarget.3069 |
0.431 |
|
| 2015 |
Wang F, Remke M, Bhat K, Wong ET, Zhou S, Ramaswamy V, Dubuc A, Fonkem E, Salem S, Zhang H, Hsieh TC, O'Rourke ST, Wu L, Li DW, Hawkins C, ... ... Wu E, et al. A microRNA-1280/JAG2 network comprises a novel biological target in high-risk medulloblastoma. Oncotarget. 6: 2709-24. PMID 25576913 DOI: 10.18632/Oncotarget.2779 |
0.585 |
|
| 2015 |
Duan W, Li R, Ma J, Lei J, Xu Q, Jiang Z, Nan L, Li X, Wang Z, Huo X, Han L, Wu Z, Wu E, Ma Q. Overexpression of Nodal induces a metastatic phenotype in pancreatic cancer cells via the Smad2/3 pathway. Oncotarget. 6: 1490-506. PMID 25557170 DOI: 10.18632/Oncotarget.2686 |
0.452 |
|
| 2015 |
Duan W, Ma Q, Ma J, Xu Q, Lei J, Wu E. Abstract A39: The activation of β1-integrin by type i collagen coupling with the Hedgehog pathway promotes the epithelial-mesenchymal transition in pancreatic cancer cells Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-A39 |
0.418 |
|
| 2015 |
Xu Q, Duan W, Lei J, Ma J, Wu E, Ma Q. Abstract A22: CXCL12-CXCR4 chemotactic pathway modulates metastasis and perineural invasion in pancreatic cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Panca2014-A22 |
0.434 |
|
| 2015 |
Wang F, Remke M, Bhat K, Wong E, Zhou S, Ramaswamy V, Dubuc A, Fonkem E, Salem S, Zhang H, Hsieh T, O'Rourke S, Wu L, Li D, Hawkins C, ... ... Wu E, et al. Abstract 3551: A microRNA-1280/JAG2 network comprises a novel biological target in high-risk medulloblastoma Cancer Research. 75: 3551-3551. DOI: 10.1158/1538-7445.Am2015-3551 |
0.596 |
|
| 2014 |
Liu J, Ma J, Wu Z, Li W, Zhang D, Han L, Wang F, Reindl KM, Wu E, Ma Q. Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signaling. Bmc Cancer. 14: 686. PMID 25240403 DOI: 10.1186/1471-2407-14-686 |
0.465 |
|
| 2014 |
Zhang G, Ye X, Ji D, Zhang H, Sun F, Shang C, Zhang Y, Wu E, Wang F, Wu F, Tian H, Liu X, Chen L, Liu K, Wang Y, et al. Inhibition of lung tumor growth by targeting EGFR/VEGFR-Akt/NF-κB pathways with novel theanine derivatives. Oncotarget. 5: 8528-43. PMID 25138052 DOI: 10.18632/Oncotarget.2336 |
0.358 |
|
| 2014 |
Hsieh TC, Lin CY, Bennett DJ, Wu E, Wu JM. Biochemical and cellular evidence demonstrating AKT-1 as a binding partner for resveratrol targeting protein NQO2. Plos One. 9: e101070. PMID 24968355 DOI: 10.1371/Journal.Pone.0101070 |
0.322 |
|
| 2014 |
Li X, Wang Z, Ma Q, Xu Q, Liu H, Duan W, Lei J, Ma J, Wang X, Lv S, Han L, Li W, Guo J, Guo K, Zhang D, ... Wu E, et al. Sonic hedgehog paracrine signaling activates stromal cells to promote perineural invasion in pancreatic cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 4326-38. PMID 24947933 DOI: 10.1158/1078-0432.Ccr-13-3426 |
0.416 |
|
| 2014 |
Duan W, Shen X, Lei J, Xu Q, Yu Y, Li R, Wu E, Ma Q. Hyperglycemia, a neglected factor during cancer progression. Biomed Research International. 2014: 461917. PMID 24864247 DOI: 10.1155/2014/461917 |
0.383 |
|
| 2014 |
Xu Q, Ma J, Lei J, Duan W, Sheng L, Chen X, Hu A, Wang Z, Wu Z, Wu E, Ma Q, Li X. α-Mangostin suppresses the viability and epithelial-mesenchymal transition of pancreatic cancer cells by downregulating the PI3K/Akt pathway. Biomed Research International. 2014: 546353. PMID 24812621 DOI: 10.1155/2014/546353 |
0.424 |
|
| 2014 |
Gong L, Ji WK, Hu XH, Hu WF, Tang XC, Huang ZX, Li L, Liu M, Xiang SH, Wu E, Woodward Z, Liu YZ, Nguyen QD, Li DW. Sumoylation differentially regulates Sp1 to control cell differentiation. Proceedings of the National Academy of Sciences of the United States of America. 111: 5574-9. PMID 24706897 DOI: 10.1073/Pnas.1315034111 |
0.309 |
|
| 2014 |
Lei J, Huo X, Duan W, Xu Q, Li R, Ma J, Li X, Han L, Li W, Sun H, Wu E, Ma Q. α-Mangostin inhibits hypoxia-driven ROS-induced PSC activation and pancreatic cancer cell invasion. Cancer Letters. 347: 129-38. PMID 24513179 DOI: 10.1016/J.Canlet.2014.02.003 |
0.428 |
|
| 2014 |
Zhou S, Wang F, Xiang S, Wong ET, Muhonen WW, Fonkem E, Hsieh T, Li DW, Zhang R, Shabb JB, Wu JM, Wu M, Wu E. Abstract 4614: Identification of two salinomycin binding targets in neuroblastoma Cancer Research. 74: 4614-4614. DOI: 10.1158/1538-7445.Am2014-4614 |
0.414 |
|
| 2014 |
Aquilato A, Lopez V, Doonan B, Hsieh TC, Pinto JT, Wu E, Wu JM. BRAF Mutation in Melanoma and Dietary Polyphenols as Adjunctive Treatment Strategy Polyphenols in Human Health and Disease. 1353-1365. DOI: 10.1016/B978-0-12-398456-2.00102-X |
0.305 |
|
| 2013 |
Han L, Peng B, Ma Q, Ma J, Li J, Li W, Duan W, Chen C, Liu J, Xu Q, Laporte K, Li Z, Wu E. Indometacin ameliorates high glucose-induced proliferation and invasion via modulation of e-cadherin in pancreatic cancer cells. Current Medicinal Chemistry. 20: 4142-52. PMID 23992308 DOI: 10.2174/09298673113209990249 |
0.407 |
|
| 2013 |
Li W, Ma J, Ma Q, Li B, Han L, Liu J, Xu Q, Duan W, Yu S, Wang F, Wu E. Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB pathway. Current Medicinal Chemistry. 20: 4185-94. PMID 23992306 DOI: 10.2174/09298673113209990251 |
0.441 |
|
| 2013 |
Hsieh TC, Bennett DJ, Lee YS, Wu E, Wu JM. In silico and biochemical analyses identify quinone reductase 2 as a target of piceatannol. Current Medicinal Chemistry. 20: 4195-202. PMID 23992305 DOI: 10.2174/09298673113209990252 |
0.376 |
|
| 2013 |
Zhou S, Wang F, Hsieh TC, Wu JM, Wu E. Thalidomide-a notorious sedative to a wonder anticancer drug. Current Medicinal Chemistry. 20: 4102-8. PMID 23931282 DOI: 10.2174/09298673113209990198 |
0.329 |
|
| 2013 |
Zhou S, Wang F, Wong ET, Fonkem E, Hsieh TC, Wu JM, Wu E. Salinomycin: a novel anti-cancer agent with known anti-coccidial activities. Current Medicinal Chemistry. 20: 4095-101. PMID 23931281 DOI: 10.2174/15672050113109990199 |
0.366 |
|
| 2013 |
Lei J, Ma J, Ma Q, Li X, Liu H, Xu Q, Duan W, Sun Q, Xu J, Wu Z, Wu E. Hedgehog signaling regulates hypoxia induced epithelial to mesenchymal transition and invasion in pancreatic cancer cells via a ligand-independent manner. Molecular Cancer. 12: 66. PMID 23786654 DOI: 10.1186/1476-4598-12-66 |
0.433 |
|
| 2013 |
Wang X, Wu E, Wu J, Wang TL, Hsieh HP, Liu X. An antimitotic and antivascular agent BPR0L075 overcomes multidrug resistance and induces mitotic catastrophe in paclitaxel-resistant ovarian cancer cells. Plos One. 8: e65686. PMID 23762410 DOI: 10.1371/Journal.Pone.0065686 |
0.367 |
|
| 2013 |
Shan T, Ma J, Ma Q, Guo K, Guo J, Li X, Li W, Liu J, Huang C, Wang F, Wu E. β2-AR-HIF-1α: a novel regulatory axis for stress-induced pancreatic tumor growth and angiogenesis. Current Molecular Medicine. 13: 1023-34. PMID 23745588 DOI: 10.2174/15665240113139990055 |
0.357 |
|
| 2013 |
Wu E, Zhou S, Bhat K, Ma Q. CA 19-9 and pancreatic cancer. Clinical Advances in Hematology & Oncology : H&O. 11: 53-5. PMID 23596673 |
0.517 |
|
| 2013 |
Li X, Ma G, Ma Q, Li W, Liu J, Han L, Duan W, Xu Q, Liu H, Wang Z, Sun Q, Wang F, Wu E. Neurotransmitter substance P mediates pancreatic cancer perineural invasion via NK-1R in cancer cells. Molecular Cancer Research : McR. 11: 294-302. PMID 23345604 DOI: 10.1158/1541-7786.Mcr-12-0609 |
0.409 |
|
| 2013 |
Liu X, Sun W, Wang X, Wu E. Abstract 4500: Tubulin binding agent BPR0L075 induces iitotic catastrophe in paclitaxel-resistant ovarian cancer cells that is independent of caspase-3 activation. Cancer Research. 73: 4500-4500. DOI: 10.1158/1538-7445.Am2013-4500 |
0.373 |
|
| 2013 |
Wu E. Abstract 4394: Salinomycin downregulates PDGFRβ and c-Myc in human medulloblastoma. Cancer Research. 73: 4394-4394. DOI: 10.1158/1538-7445.Am2013-4394 |
0.43 |
|
| 2012 |
Li X, Ma Q, Duan W, Liu H, Xu H, Wu E. Paracrine sonic hedgehog signaling derived from tumor epithelial cells: a key regulator in the pancreatic tumor microenvironment. Critical Reviews in Eukaryotic Gene Expression. 22: 97-108. PMID 22856428 DOI: 10.1615/Critreveukargeneexpr.V22.I2.20 |
0.381 |
|
| 2012 |
Li X, Ma Q, Xu Q, Liu H, Lei J, Duan W, Bhat K, Wang F, Wu E, Wang Z. SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway Cancer Letters. 322: 169-176. PMID 22450749 DOI: 10.1016/J.Canlet.2012.02.035 |
0.633 |
|
| 2012 |
Bhat K, Wang F, Ma Q, Li Q, Mallik S, Hsieh TC, Wu E. Advances in biomarker research for pancreatic cancer. Current Pharmaceutical Design. 18: 2439-51. PMID 22372502 DOI: 10.2174/13816128112092439 |
0.592 |
|
| 2012 |
Li X, Ma Q, Xu Q, Duan W, Lei J, Wu E. Targeting the cancer-stroma interaction: A potential approach for pancreatic cancer treatment Current Pharmaceutical Design. 18: 2404-2415. PMID 22372501 DOI: 10.2174/13816128112092404 |
0.421 |
|
| 2012 |
Liu H, Ma Q, Xu Q, Lei J, Li X, Wang Z, Wu E. Therapeutic potential of perineural invasion, hypoxia and desmoplasia in pancreatic cancer Current Pharmaceutical Design. 18: 2395-2403. PMID 22372500 DOI: 10.2174/13816128112092395 |
0.418 |
|
| 2012 |
Zhang G, Wang Y, Zhang Y, Wan X, Li J, Liu K, Wang F, Liu K, Liu Q, Yang C, Yu P, Huang Y, Wang S, Jiang P, Qu Z, ... ... Wu E, et al. Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy. Current Molecular Medicine. 12: 163-76. PMID 22280355 DOI: 10.2174/156652412798889063 |
0.39 |
|
| 2012 |
Li W, Ma Q, Liu J, Han L, Ma G, Liu H, Shan T, Xie K, Wu E. Hyperglycemia as a mechanism of pancreatic cancer metastasis. Frontiers in Bioscience (Landmark Edition). 17: 1761-74. PMID 22201834 DOI: 10.2741/4017 |
0.404 |
|
| 2012 |
Wu E. Abstract 5532: Anti-cancer activities of tea epigallocatechin-3-gallate in breast cancer patients under radiotherapy Cancer Research. 72: 5532-5532. DOI: 10.1158/1538-7445.Am2012-5532 |
0.396 |
|
| 2012 |
Li W, Ma Q, Wu E. Perspectives on the Role of Photodynamic Therapy in the Treatment of Pancreatic Cancer International Journal of Photoenergy. 2012: 637429. DOI: 10.1155/2012/637429 |
0.379 |
|
| 2011 |
Zhang D, Ma Q, Wang Z, Zhang M, Guo K, Wang F, Wu E. β2-adrenoceptor blockage induces G1/S phase arrest and apoptosis in pancreatic cancer cells via Ras/Akt/NFκB pathway. Molecular Cancer. 10: 146. PMID 22118662 DOI: 10.1186/1476-4598-10-146 |
0.336 |
|
| 2011 |
Han L, Ma Q, Li J, Liu H, Li W, Ma G, Xu Q, Zhou S, Wu E. High glucose promotes pancreatic cancer cell proliferation via the induction of EGF expression and transactivation of EGFR. Plos One. 6: e27074. PMID 22087246 DOI: 10.1371/Journal.Pone.0027074 |
0.363 |
|
| 2011 |
Shan T, Ma Q, Guo K, Liu J, Li W, Wang F, Wu E. Xanthones from Mangosteen Extracts as Natural Chemopreventive Agents: Potential Anticancer Drugs Current Molecular Medicine. 11: 666-677. PMID 21902651 DOI: 10.2174/156652411797536679 |
0.372 |
|
| 2011 |
Tian Z, Shen J, Wang F, Xiao P, Yang J, Lei H, Kazlauskas A, Kohane IS, Wu E. Cambogin is preferentially cytotoxic to cells expressing PDGFR. Plos One. 6: e21370. PMID 21712951 DOI: 10.1371/Journal.Pone.0021370 |
0.399 |
|
| 2011 |
Wang F, Bhat K, Doucette M, Zhou S, Gu Y, Law B, Liu X, Wong ET, Kang JX, Hsieh TC, Qian SY, Wu E. Docosahexaenoic acid (DHA) sensitizes brain tumor cells to etoposide-induced apoptosis. Current Molecular Medicine. 11: 503-11. PMID 21663587 DOI: 10.2174/156652411796268740 |
0.598 |
|
| 2011 |
Shan T, Ma Q, Zhang D, Guo K, Liu H, Wang F, Wu E. β2-adrenoceptor blocker synergizes with gemcitabine to inhibit the proliferation of pancreatic cancer cells via apoptosis induction. European Journal of Pharmacology. 665: 1-7. PMID 21570961 DOI: 10.1016/J.Ejphar.2011.04.055 |
0.439 |
|
| 2011 |
Li J, Ma Q, Liu H, Guo K, Li F, Li W, Han L, Wang F, Wu E. Relationship between neural alteration and perineural invasion in pancreatic cancer patients with hyperglycemia. Plos One. 6: e17385. PMID 21386984 DOI: 10.1371/Journal.Pone.0017385 |
0.345 |
|
| 2011 |
Zhang M, Ma Q, Hu H, Zhang D, Li J, Ma G, Bhat K, Wu E. Stem cell factor/c-kit signaling enhances invasion of pancreatic cancer cells via HIF-1α under normoxic condition. Cancer Letters. 303: 108-17. PMID 21320746 DOI: 10.1016/J.Canlet.2011.01.017 |
0.616 |
|
| 2010 |
Ma J, Meng Y, Kwiatkowski DJ, Chen X, Peng H, Sun Q, Zha X, Wang F, Wang Y, Jing Y, Zhang S, Chen R, Wang L, Wu E, Cai G, et al. Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade. The Journal of Clinical Investigation. 120: 103-14. PMID 20038814 DOI: 10.1172/Jci37964 |
0.379 |
|
| 2010 |
Wang F, Moseman A, Doucette M, Bhat K, Li X, Tian Z, Zhang H, Law SH(, Kohane I, Wu E. Abstract 288: PDGFR alpha and PDGFR beta differentially regulate cell proliferation and migration/invasion in medulloblastoma cells Cancer Research. 70: 288-288. DOI: 10.1158/1538-7445.Am10-288 |
0.576 |
|
| 2009 |
Wang S, Liu Q, Zhang Y, Liu K, Yu P, Liu K, Luan J, Duan H, Lu Z, Wang F, Wu E, Yagasaki K, Zhang G. Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action. Molecular Cancer. 8: 81. PMID 19796390 DOI: 10.1186/1476-4598-8-81 |
0.416 |
|
| 2009 |
Yu P, Liu Q, Liu K, Yagasaki K, Wu E, Zhang G. Matrine suppresses breast cancer cell proliferation and invasion via VEGF-Akt-NF-kappaB signaling. Cytotechnology. 59: 219-29. PMID 19760125 DOI: 10.1007/S10616-009-9225-9 |
0.423 |
|
| 2009 |
Tian Z, An N, Zhou B, Xiao P, Kohane IS, Wu E. Cytotoxic diarylheptanoid induces cell cycle arrest and apoptosis via increasing ATF3 and stabilizing p53 in SH-SY5Y cells. Cancer Chemotherapy and Pharmacology. 63: 1131-9. PMID 18836721 DOI: 10.1007/S00280-008-0832-5 |
0.318 |
|
| 2008 |
Wu E, Palmer N, Tian Z, Moseman AP, Galdzicki M, Wang X, Berger B, Zhang H, Kohane IS. Comprehensive dissection of PDGF-PDGFR signaling pathways in PDGFR genetically defined cells. Plos One. 3: e3794. PMID 19030102 DOI: 10.1371/Journal.Pone.0003794 |
0.314 |
|
| 2008 |
Tian Z, Shen J, Moseman AP, Yang Q, Yang J, Xiao P, Wu E, Kohane IS. Dulxanthone A induces cell cycle arrest and apoptosis via up-regulation of p53 through mitochondrial pathway in HepG2 cells. International Journal of Cancer. 122: 31-8. PMID 17847033 DOI: 10.1002/Ijc.23048 |
0.333 |
|
| 2007 |
Tian Z, Si J, Chang Q, Zhou L, Chen S, Xiao P, Wu E. Antitumor activity and mechanisms of action of total glycosides from aerial part of Cimicifuga dahurica targeted against hepatoma. Bmc Cancer. 7: 237. PMID 18166137 DOI: 10.1186/1471-2407-7-237 |
0.364 |
|
| 2007 |
Tian Z, Pan R, Chang Q, Si J, Xiao P, Wu E. Cimicifuga foetida extract inhibits proliferation of hepatocellular cells via induction of cell cycle arrest and apoptosis. Journal of Ethnopharmacology. 114: 227-33. PMID 17881166 DOI: 10.1016/J.Jep.2007.08.008 |
0.323 |
|
| 2007 |
Tian Z, Xu L, Chen S, Zhou L, Yang M, Chen S, Xiao P, Wu E. Cytotoxic activity of schisandrolic and isoschisandrolic acids involves induction of apoptosis. Chemotherapy. 53: 257-62. PMID 17496413 DOI: 10.1159/000102582 |
0.329 |
|
| 2007 |
Zhang H, Bajraszewski N, Wu E, Wang H, Moseman AP, Dabora SL, Griffin JD, Kwiatkowski DJ. PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR. The Journal of Clinical Investigation. 117: 730-8. PMID 17290308 DOI: 10.1172/Jci28984 |
0.369 |
|
| 2006 |
Tian Z, Zhou L, Huang F, Chen S, Yang J, Wu E, Xiao P, Yang M. Anti-cancer activity and mechanisms of 25-anhydrocimigenol-3-O-beta-D-xylopyranoside isolated from Souliea vaginata on hepatomas. Anti-Cancer Drugs. 17: 545-51. PMID 16702811 DOI: 10.1097/00001813-200606000-00008 |
0.389 |
|
| 2005 |
Feuerhake F, Monti S, Blank J, Wu E, Chen W, Golub TR, Shipp MA. Signatures of Response to the Proteasome Inhibitor Bortezomib in Diffuse Large B-Cell Lymphoma. Blood. 106: 608-608. DOI: 10.1182/Blood.V106.11.608.608 |
0.31 |
|
| 2003 |
Fromigué O, Louis K, Wu E, Belhacène N, Loubat A, Shipp M, Auberger P, Mari B. Active stromelysin-3 (MMP-11) increases MCF-7 survival in three-dimensional Matrigel culture via activation of p42/p44 MAP-kinase. International Journal of Cancer. 106: 355-63. PMID 12845673 DOI: 10.1002/Ijc.11232 |
0.364 |
|
| 2001 |
Wu E, Mari BP, Wang F, Anderson IC, Sunday ME, Shipp MA. Stromelysin-3 suppresses tumor cell apoptosis in a murine model Journal of Cellular Biochemistry. 82: 549-555. PMID 11500932 DOI: 10.1002/Jcb.1181 |
0.349 |
|
| Show low-probability matches. |